Injuria renal aguda

Insuficiencia Renal Aguda (IRA)

1. Conceptos Generales

• Definición:
  • IRA is a clinical syndrome characterized by a sudden alteration in the body's homeostasis.
  • Various causes lead to a reduced capacity of the kidneys to eliminate nitrogenous waste products and disturbances in electrolyte and fluid balance.
  • Often manifests as insufficient diuresis, developing over hours or days.
  • Diagnosis is based on elevated serum creatinine and urea levels above baseline, along with new markers of kidney damage.
  • Diagnostic criteria and staging:
    • RIFLE criteria: Risk, Injury, Failure, Loss, and End-stage renal disease.
    • Developed during the 2nd consensus conference of the Adequate Dialysis Quality Initiative (ADQI) in 2002.
    • AKIN (Acute Kidney Injury Network) criteria (2007): Modified RIFLE by removing glomerular filtration rate criteria and focusing on creatinine elevation and decreased diuresis.
    • KDIGO (Kidney Disease Improving Global Outcomes) criteria (2012): Defines IRA based on serum creatinine increase over time or urine output, with three severity levels.
    • Recommends determining the cause and type of IRA, considering it a syndrome.
    • Acute Kidney Disease (AKD): Proposed by ADQI for when renal function deterioration lasts more than 7 days; if it persists beyond 90 days, it's classified as Chronic Kidney Disease (CKD).

1.2. Oliguria and Anuria

• Normal diuresis volume varies based on the body's needs for regulating volemia and plasma osmolality.
• Oliguria: Urine output less than 400 mL/day.
• Anuria: Urine output less than 100 mL/day.
• Hourly monitoring:
  • <0.5 ml/(kg·h) for AKIN/KDIGO stages 1 and 2.
  • <0.3 ml/(kg·h) for AKIN/KDIGO stage 3.

1.3. Fisiopatología y Clasificación

1.3.1. IRA Prerrenal

• Occurs when renal perfusion is compromised, triggering hormonal and sympathetic nervous responses.
• Results in decreased urine flow and reduced sodium and chloride excretion.
• Urine is more concentrated with waste solutes (urea, creatinine, phosphates, ammonium), leading to relatively high osmolality compared to plasma.
• Daily requirement to eliminate approximately 800 milliosmoles of solutes.
  • Achieved by producing urine as concentrated as 1,200 mOsm/kg or as dilute as 100 mOsm/kg, depending on the need to conserve or eliminate water.
  • Hypothalamic osmostat controls vasopressin secretion, which regulates water channels (aquaporin-2) in the renal collecting tubule.
• If urine volume drops below 500 mL/day, waste products are not adequately eliminated, leading to azotemia.
• Reversible upon restoring the underlying cause of hypoperfusion.
• Associated with oliguria (less than 400 mL of urine per day, 200 mL in 12 hours, or less than 20 mL/hour in catheterized patients).
• Hepatorenal syndrome: A model of functional acute renal failure.

1.3.2. IRA Parenquimatosa o Intrínseca

• Also referred to as Renal IRA.
• Can be oliguric, anuric, or with preserved diuresis (but with poorly concentrated urine).
• Prolonged or severe hypoperfusion can cause hypoxic and oxidative damage to renal tubular cells, leading to loss of polarity, necrosis, and apoptosis, resulting in established renal failure.
  • The S3 segment of the proximal tubule and the collecting tubule are most susceptible.
  • Recovery may take days or weeks after restoring perfusion.
  • Acute Tubular Necrosis (ATN): Term used clinically based on exclusion of other causes, though originally an anatomical-pathological term.
• Other causes of intrinsic IRA:
  • Immunological causes (systemic or local): vasculitis, immunoallergic interstitial nephritis from drugs.
  • Vascular problems: atheroembolic disease, embolisms, or thrombosis in renal arteries or veins.
  • Nephrotoxins:
    • Xenobiotics (aminoglycosides, iodinated contrasts) with direct toxicity on tubular cells.
    • Drugs modifying renal hemodynamics (renin-angiotensin system blockers, NSAIDs).
    • Triple "Whammy": Combination of NSAIDs, renin-angiotensin system blockers, and diuretics increases the risk of IRA in elderly patients.
      • A study showed a 30% increased risk of IRA with this combination compared to two drugs, and an 80% increase in the first 30 days of treatment.
    • Endogenous toxins:
      • HEME proteins (containing iron): Myoglobin (17 kDa protein) released from muscle damage (rhabdomyolysis).
        • When plasma concentration exceeds 100 mg/dL, it overwhelms the proximal tubule's capacity to catabolize it, leading to obstruction and toxicity, especially in acidic urine.
        • Severe rhabdomyolysis (e.g., crush syndrome) is associated with hypovolemia and renal vasoconstriction.
        • Electrolyte disturbances (hypocalcemia, hyperkalemia, acidosis, hyperphosphatemia) limit cardiac output and renal perfusion.
      • Hemoglobinuria (from massive hemolysis):
        • Less frequent due to higher molecular weight than myoglobin, making it harder to filter.
      • Overproduction of immunoglobulin light chains in plasma cell dyscrasias (e.g., multiple myeloma).
        • Some substances can cause tubular damage through crystallization (acyclovir, methotrexate) or endogenous substances like urate (tumor lysis syndrome).
• Inflammation: Systemic or local immunological causes (vasculitis, immunoallergic interstitial nephritis), vascular problems (atheroembolic disease, embolisms, thrombosis).
• Multiple mechanisms often contribute to renal failure (hypoperfusion, direct toxic injury).

1.3.3. IRA Postrenal u Obstructiva

• Occurs when urinary flow obstruction affects kidney function, potentially leading to anuria if bilateral or in a solitary functioning kidney.
• High degree of reversibility; renal function rapidly returns to initial values upon correcting the obstruction (catheterization or nephrostomy).

2. Epidemiología y Pronóstico

• Epidemiological data varies due to differing methodologies and definitions.
• Incidence in the USA: 2,880 per million population (pmp)/year based on state data, and 5,000 according to a California insurer.
• Important to differentiate between community-acquired and hospital-acquired IRA, and cases in critical care units.
• Community-acquired IRA is 70% prerenal and 17% obstructive.
• IRA complicates more than 5% of all hospital admissions and up to one-third of patients in critical care units.
• Using RIFLE criteria, the percentage can rise to 20% of all hospitalized patients, often associated with ischemia, sepsis, drugs, and iodinated contrasts.
• In critical care units, the cause is often multifactorial and related to multiorgan failure.
• Overall, more than half of cases are prerenal, 40% are renal/parenchymal, and 5% are postrenal.
• Mortality varies from 15% in community-acquired IRA to over 50% in those requiring replacement therapy in the ICU.
• Most surviving patients recover total or partial renal function.
• 10-20% of severe IRA cases require renal replacement therapy at discharge.
• Some of these patients may recover function and discontinue dialysis, but many progress to end-stage chronic renal failure (stage 5).

3. Etiología

• Refer to Table 1 for a summary of IRA causes.
• IRA associated with sepsis is common in infectious conditions,
  • May precede the infection, increasing the risk, accompany sepsis from the beginning, or appear later.
  • Hemodynamic responses, inflammation, endothelial damage, blood cell aggregation in small vessels, ischemia, and metabolic changes (from aerobic to oxidative phosphorylation resulting in lactate) lead to cell death or dysfunction.
  • Inflammatory mediators, pathogen-derived products, antibiotics, and iodinated contrasts exacerbate renal damage.
  • Initial resuscitation with large amounts of intravenous fluids can lead to volume overload with interstitial edema, worsened by increased vascular permeability.
• Sepsis (infection plus organ failure) is the most frequent cause of IRA in critical care units, with more than half of those developing it presenting with IRA of varying severity.
• In the context of the COVID-19 pandemic, SARS-CoV-2 causes direct damage to endothelial, epithelial, tubular cells, and podocytes.
  • Also triggers cytokine storms, activates angiotensin II, dysregulates complement, and causes hypercoagulability and microangiopathy.
  • Indirect damage from severe pulmonary disease and iatrogenic effects from treatments also occur.

4. Diagnóstico

• Algorithm for differential diagnosis in Figure 2.
• Diagnostic steps should follow a logical sequence, from simple to sophisticated, least to most aggressive, and consider frequent causes before rare ones.
• Table 2 outlines the steps for etiologic and differential diagnosis of IRA.
• Multiple factors can occur simultaneously or sequentially.

4.1. La clínica en el diagnóstico de la IRA

• Clinical history is crucial for the correct approach to IRA and all clinical syndromes.
• Anamnesis and thorough physical examination offer clues for potential etiologies.
• Gather information on allergic history, drug use, toxic exposures, gastroenteritis, fluid losses, bleeding, or signs/symptoms pointing towards a third space fluid shift.
• Inquire about vascular history (arteriosclerosis, invasive radiological procedures using iodinated contrast, cardiac arrhythmia, etc.).
• Information on recent surgeries, pregnancies, obstetric complications, prostate issues, macroscopic hematuria, renal colic, or passage of stones/sand.
• Investigate data suggesting lymphoproliferative or tumoral processes, recent trauma, signs/symptoms of infectious disease, and conduct epidemiological analysis when appropriate.
• The most frequent cases of IRA stem from renal hypoperfusion (secondary to dehydration from digestive losses, etc.) and toxins, such as antibiotics or iodinated contrast agents.
• Less frequently utilized drugs (antimicrobials like amphotericin B, vancomycin, aciclovir, ganciclovir, pentamidine, foscarnet, etc.), bisphosphonates like zoledronic acid, or antineoplastic agents (cisplatin, ifosfamide) frequently cause acute renal failure.
• Immune checkpoint inhibitors cause IRA via immunoallergic mechanisms.
• Anesthetics (enflurane) rarely cause IRA.
• Intoxications from carbon tetrachloride (CCl4), ethylene glycol, or mushrooms, though rare, should be considered as prompt diagnosis may be life-saving.
• Hemoptysis or other signs of pulmonary hemorrhage will point toward a "lung-kidney" condition of infectious or autoimmune etiology (Goodpasture syndrome, lupus, granulomatous angeitis or microscopic polyangeitis) or may simply represent pulmonary edema or a neoplastic process.
• Granulomatous angeitis presents with pulmonary involvement in 90% of cases, microscopic polyangeitis in 50%, and allergic granulomatosis in 70%, while renal involvement presents in 80, 90, and 45%, respectively.
• Vasculitis frequently manifests in a subacute manner, but experience dictates inclusion in this chapter as many cases have presented as a case of
• Physical examination should begin with a general assessment of the patient:
  • Level of consciousness, hydration status, skin coloration, and distal perfusion, as well as respiratory rate and ease, along with temperature.
  • Followed by hemodynamic assessment, including heart rate, blood pressure measurements, and venous status, along with cardiopulmonary auscultation.
  • Abdominal assessment should aim to ascertain the size of the organs, localize potential areas of pain or inflammation, rule out peritoneal irritation, and assess intestinal motility.
• Cervical, axillary, and inguinal adenopathies should be researched along with excluding complicated hernias.
• Inspect the limbs seeking wounds, bites, stings or punctures that may have introduced toxins or microorganisms or substances that indirectly caused renal damage via rhabdomyolysis, for example.
• Certain cutaneous lesions appear in allergic diseases (drug-induced nephritis), autoimmune disorders (vasculitis, systemic lupus, Schönlein-Henoch purpura), in infectious diseases (endocarditis, meningitis, etc.) or vascular disorders (livedo reticularis in atheroembolic disease or catastrophic antiphospholipid syndrome).
• Atheroembolic disease is triggered by debris coming off a fractured plaque inclusive of little particulate & cholesterol crystals impacting in smaller sized vessels, arterioles, and capillaries (40µm particles will pack into afferent arterioles and cholesterol deposits may even reach the capillaries).
• Likewise important during the clinical phase is to not be at ease with the IRA diagnosis.
• Often behind this one syndrome is quite a severe affliction as with regards to acute complicated myocardial infarction one from emboli, atheroembolic disorder, lymphoproliferative or neoplastic process with retroperitoneal invasion, multiple myeloma, etc.
• An important note with regards to renal failure, which presents during its own final stages in many terminally ill individuals.

4.2 Análisis bioquímicos de urgencia.

4.2.1. Análisis básicos.

• Determination in serum or plasma of creatinine, urea or urea nitrogen, mono and divalent ions, pH and blood gases (venous, capillary or arterial according to the clinical picture), hematic count with leukocyte count, in addition to a urine reagent strip.
• Depending on the clinical manifestations, the enzymes creatine phosphokinase (CK), lactodehydrogenase (LDH), amylase or transaminases can also be requested urgently.
• The coagulation study will be requested if we foresee the performance of a surgical intervention, canalization of central line or renal biopsy.
• It will also be indicated if there is thrombocytopenia, liver failure or sepsis.

4.2.2. Parámetros de funcionalidad.

• They are aimed at determining whether the kidney is responding pathophysiologically to inadequate renal perfusion or whether there is actually damage to this organ that prevents its correct function.
• The correct interpretation of these parameters is framed in the scenario of the patient with oliguria who is not under the action of diuretics.
• In prerenal acute renal failure, they fundamentally translate secondary hyperaldosteronism and stimulation of the antidiuretic hormone or vasopressin (ADH).
• The first, by acting on the nonspecific receptors for mineralocorticoids, located in the main cells of the collecting tubule of the distal nephron and the collecting tubule, favors the electrogenic reabsorption of Na+ through the epithelial sodium channel (generating a negative electrical potential in the tubular light) and indirectly favoring the tubular secretion of H+ and K+.
• ADH stimulation acting on its receptors in the cells of the collecting tubules favors the exit of water through aquaporin-2 from the tubular light to the cell and through aquoporin-3 and 4 from the tubule to the interstitium and from here to the circulatory stream.
• As a result of all this pathophysiological response, a urine with little sodium content, with relatively high potassium content and relatively concentrated (with high osmolality) is given as a result.
• The description of the parameters that express functionality is detailed in Table 3.
• For their calculation, we must request from the laboratory, in addition to the parameters mentioned above, a simultaneous determination of urinary ions (Na+, K+, Cl-), urea and creatinine.
• The osmolality in serum and urine (measured indirectly by the variation in the freezing point and its comparison with solutions of known osmolality at different concentrations, and expressed in milliosmoles per kilogram) may help us in the categorization of kidney failure.
• Its estimation from the most representative molecules and ions can be simple in serum or plasma, but more complicated in urine (see later).
• If osmolality is not available, the relative density of urine can provide an orientation: a density greater than 1,018 correlates with a concentrated urine and that close to 1,010 reveals that the urine is isostenuric (of similar osmolality to plasma).
• Once this point has been reached and if we have reasonably ruled out the existence of prerenal IRA, we should request an imaging test. Of choice: abdominal ultrasound.

4.3. Ecografía abdominal.

• Being a non-invasive, relatively inexpensive test that can even be performed at the patient's bedside, it becomes a "gold nugget" in the differential diagnosis algorithm of kidney failure.
• The patterns we can find are listed in Table 4 and can be seen in Figure 3 (panels a, b, c and d).
• In cases of small and hyperechogenic kidneys and kidneys with large bilateral
• And decreased renal parenchyma cysts, we will find a chronic kidney disease that is in its evolutionary stage of progressive deterioration or, before a reacreation of its kidney failure.
• It is not uncommon to face a patient for the first time with the suspicion of IRA and treat a patient with advanced chronic nephropathy unknown to all or to a case of autosomal dominant polycystic kidney disease (ignorance of family history, legal father different from the natural mutation de novo).
• The dilation of the excretory pathway, so that it causes IRA, must affect both kidneys, the common excretory pathway or a kidney whenever this provides most or all of the kidney function (the other kidney being aplasic or hypoplasic, ischemic, annulled by an inflammatory or obstructive process, removed by tumor, infectious, vascular or traumatic cause).
• Although infrequent, a kidney obstruction may course without significant dilatation of systems. This has been described in monorrenos functionals of many years of evolution and in some elderly patient. Perhaps this is explained by the lack of distensibility of these bodies.
• The decrease in echogenicity of renal papillae has been described in some nephropathy as in
• Immunoallergic interstitial nephritis. However, we consider this sign to be somewhat nonspecific.
• The existence of parenchymal IRA without
• That we find a clear ischemic or exogenous or endogenous toxic cause should make us count on other laboratory tests and even with the histological analysis of the kidney.

4.4. Pruebas de laboratorio y otras exploraciones complementarias.

4.4.1. El análisis urinario.

• The different elements that we can find in the urine are summarized in Table 5.
• The microscopic analysis of the urine can alert us about the presence of red blood cells.
• If these are accompanied by significant proteinuria, hematic cylinders and an altered morphology (with phase contrast microscopy), it orients us towards the glomerular origin of the disease, such as a primary or secondary glomerulonephritis to vasculitis, connective tissue disease or infectious process.
• The presence of eosinophils in urine (with the corresponding Wright staining, after buffering the urine) may support the diagnosis of allergic interstitial nephropathy.
• However, urine eosinophils can be observed in atheroembolic disease and in acute pyelonephritis.
• The existence of oxalate crystals can guide us, depending on the context, to ethylene glycol poisoning.
• Renal cylinders in functional IRA are clear, hyaline, and are produced by the precipitation of Tamm Horsfall uromucoid in a concentrated urine; while in an NTA they are pigmented, brownish and with epithelial cells of flaking.
• The cylinders may contain red blood cells in proliferative glomerulonephritis and leukocytes in allergic interstitial nephritis.
• Figure 4 shows images of cylinders and Figure 5 dysmorphic red blood cells.

4.4.2. Pruebas serológicas.

• The detection of anticytoplasmatic antibodies of neutrophil (ANCA) associated with certain small vessel vasculitis, such as microscopic polyangeitis, granulomatous angeitis or allergic granulomatosis may prove useful for its diagnosis and the evolution and response to treatment.
• They are objectified by indirect immunofluorescence of sera with normal neutrophils or by ELISA against the specific antigen: The C-ANCA pattern (granular cytoplasmic) is that of immunofluorescence whose antigenic specificity almost always corresponds to proteinase 3 (PR3); while that of the P-ANCA pattern (perinuclear) usually does so with myeloperoxidase (MPO).
• The first pattern is positive in 80% of granulomatous angeitis, in 30% of Polyangeitis microscopy, in 30% of idiopathic pauci-immune extracapillar glomerulonephritis and in 35% of allergic granulomatosis.
• While the second pattern is in 50% of polyangeitis microscopy, 50% of extracapillar glomerulonephritis, 35% allergic granulomatosis and in other autoimmune processes such as rheumatoid arthritis, autoimmune hepatopathies and inflammatory bowel diseases.
• Antinuclear antibodies, especially anti-DNA, and anti-Scl70 (antitopoisomerase I) and anti RNA polymerase III, are analyzed for the evaluation of SLE and scleroderma, respectively.
• Antiphospholipid syndrome will rarely cause acute kidney failure, but there is a catastrophic presentation that presents distal necrosis, myo-
• Cardiac and renal failure. We will suspect it in the event of a history of thrombosis, repeated abortions or other more non-specific alterations and an elongated partial thromboplastin time:
• Clinical suspicion will justify requesting anticardiolipin titers, Beta-2 glycoprotein and lupus anticoagulant. Anti-glomerular basement membrane antibodies in the suspicion of Goodpasture syndrome will complete the study.
• Some serological tests in relation to infectious processes such as legionella or leptospirosis, or virus serology, may be requested according to the clinical or epidemiological context of the patient with IRA.

4.4.3. Análisis de proteínas.

• Plasma electrophoresis and immunofixation and quantification of light chains in urine (search for Bence-Jones proteinuria) will be indicated in the event of kidney failure of unclear cause or in the presence of hypercalcemia or disproportionate anemia.
• In some myelomas, especially in light chains, we may not observe monoclonal peak in serum and only the light chain appears in urine.
• Since if this does not circulate polymerized and does so as a monomer or as a dimer (22 o

4.4.4. Análisis hematológicos.

• A blood smear can identify us the existence of schistocytes, typical of a uremic hemolytic syndrome (HUS) or thrombocytopenic purpura (TTP), or malignant arterial hypertension.
• Thrombocytopenia, anemia (with reticulocytosis and decreased haptoglobin) and elevation of LDH in serum, are presented in these microangiopathic diseases.
• In this regard, the history of gastrointestinal infection by enteropathogenic Escherichia coli O157 or Shigella (typical Hemolytic Uremic syndrome), family history (mutations related to the complement chain or antibodies against regulatory factors –atypical primary Hemolytic Uremic Syndrome-) and causes of atypical HUS secondary to infections (pneumococcus, influenza A- H1N1, cytomegalovirus, HIV), neoplasms, pregnancy (HELLP syndrome, fatty liver of pregnancy) or taking certain immunosuppressive drugs such as tacrolimus, will warn us.
• A decreased activity (<5-10%) of the metalloproteinase enzyme ADAMS-13 will support the diagnosis of thrombotic thrombocytopenic purpura (TTP).
• Finally, it will sometimes be required to
• Look for the existence in peripheral blood and marrow of tumor cells to reach the diagnosis of leukemia, lymphomas and myeloma multiple by cytological analysis, of immunophenotype, genetic and histological.

4.4.5. Estudios microbiológicos.

• Studies in place to confirm certain infections such as leptospira, legionella, enterobacterias (and serotype of E. coli if applicable), serial blood cultures against obvious sepsis or more larval infections such as endocarditis or hidden abscess, and viral serological and culture tests according to the concomitant clinic.

4.4.6. El gap osmolar.

• The osmolar gap in serum may help us in the suspicion of poisoning with molecules of low molecular weight, as is the case of ethylenglycol (present in antifreeze and refrigeration fluids), isopropanol, acetone, ethanol and methanol (burning alcohol).
• It consists of calculating the difference between the measured osmolality with an osmometer and the estimated through the calculation with the most abundant molecules and of low molecular weight that we usually analyze.
• Osmolality is usually measured well by the variation of the freezing point (to more osmolality will decrease the cryoscopic point) or by the variation in the evaporation pressure.
• The osmolality estimation is calculated as follows:
  $Osm (mOsm/Kg)= 2[Na (mEq/L)]+[glucosa (mMol/L)] +[Urea (mMol/L)]$
  $Osm (mOsm/Kg)= 2[Na (mEq/L)]+[glucosa (mg/dL)]/18 +[Urea (mg/dL)]/6$
  $Osm (mOsm/Kg)= 2[Na (mEq/L)]+[glucosa (mg/dL)]/18 +[BUN (mg/dL)]/2,8$
• The concentration of Na+ is multiplied by 2; Chlorine and sodium are strong ions. Both non-dissociated NaCl (15% at pH 7.40) and each ion of Cl- and each ion of Na+ dissociated (85%) are considered. That is, for each atom of Na+ there will be:
  $0,15[NaCl]+0,85[Na+]+0,85[Cl-]$
• Which results in 1.85 particles (ions plus molecules). As the concentration of a substance in plasma water is equal to its concentration in plasma between 1 - Φ (where Φ=0.0107 x total plasma proteins in gr/dL), resulting for a protein concentration of 7 g/dL the following adjustment:
  $1,85[Na]/0,925=2[Na]$
• Where, CwA is the concentration of a substance "A" in plasma water and CpA its measured concentration in plasma. The normal value of osmolality is 280-295 mOsm/Kg
• If we included ethanol in the formula, we would divide its concentration by 4.6 in mg/dL (p.m. of ethanol 46 Da), that of ethylenglycol by 6.2 (p.m. 62 Da), that of isopropanol by 6 (p.m. 60 Da) and that of methanol by 3.2 (p.m. 32 Da).
• This allows us if we do not know the concentration of the toxic to deduce it from the osmolar gap or to suspect the involvement of more than one toxic if we do not square

4.4.7. El examen de fondo de ojo.

• The eyeground examination will help us when assessing a possible Atheroembolic disease

4.5. Pruebas de imagen diferentes a la ecografía.

• In addition to ultrasound, simple X-ray film of abdomen, chest and bones as relevant, one should consider examinations directed to discard or show a vascular pathology or obstructive uropathy.

4.5.1. Para el despistaje de la uropatía obstructiva.

• The intent is primarily discarding that the existing urinary obstruction went undetected during the ultrasound examination or to establish topographical localization or determine the etiologic diagnosis to the obstructive uropathy.
• Along those lines a computer-generated axial tomogram the intravenous pyelogram (if we have a nephrostomy catheter) and a retrograde pyelogram or cystogram will help get you started.
• A uro-magnetic resonance scan (T2 shows a sharp image of fluid) proves a fine alternative due to not requiring the administration of any form of a contrast media.

4.5.2. Para el despistaje de patología vascular.

• When under suspicion with regards to kidney infarction then a kidney arteriogram proves test of first choice.
• In those cases where this confirms thrombo-emboli present or existing it's OK to maintain this catheter situated in the kidney artery whilst simultaneously infusing some local fibrinolytics during any initial time frame to 24hrs.
• In cases of suspected with regards to venal thrombosis one should consider phlebography.
• A helical axial computer tomogram with several 64-head detectors will potentially serve up vital material without those risks associated with some of the other above-mentioned exams.
• A Doppler ultrasound might sometimes help decision-making, either pointing toward taking on aortography and/or even phlebography studies.
• Isotope scanners could potentially generate diagnostic data regarding any vascular pathology using methods generally non-intrusive, yet might often waste lots of invaluable time!

4.6. Biopsia Renal

• Renal biopsy is minimally invasive nowadays but not risk-free.
• The best option is percutaneous biopsy.
• It has traditionally been done via US guidance with automated biopsy guns.
• These have really minimized complications w/ reasonable diagnostic outcomes.
• In special instances, surgical biopsy or maybe transjugular biopsy are preferred.
• The last option is for coagulopathy/obesity or in cases where a liver biopsy is taken at the same time.
• Sample requirements should include core samples and a fixative w/formalin.
• Sections are stained with eosin, PAS, methenamine of Jones for BM highlighting or Masson trichrome stain for collagen. Or specifically with Congo-red/Thioflavin T for amyloid deposits!
• Core sample frozen rapidly for immunofluorescence studies in relation specifically to the Ig, light chain, complements, fibrinogen, properdin, etc, elements.
• And ultimately an extra amount goes directly into some glutaraldehyde solution and ultimately post-fixed in osmium and embedded w/ epoxi- resin intended to be an ultrathin cutout ultimately. Furthermore, a sample gets exposed directly with immunohistochemistry techniques inclusive against all P components for polyomavirus, C4d-complement, etc elements.
• Biopsies in intubated/ventilated patients are somewhat tricky.
• In our hand if performed laterally then ventilator disconnection doesn't impact a thing!
• Indications against acute renal failure can't get narrowly limited only into the diagnostic curiosity; in fact, therapeutic impact has proven necessary!
• Remember usually one is faced directly against some necrosis of the tubules! With that said a few diseases warrant biopsies, especially ones like autoimmune diseases (vasculitis, glomerularnephritis- or anti-GBM or ANCA+). Or in the setting that analyses are focused directly toward analyzing one's degree of involvement-and thus an analysis based upon an autoimmune disorder.
• It's implied if any prolonged ATN without recovery!
• With this type of situation the final diagnosis ends up turning quite unexpected, showing typically corticomedullary necrosis and generally tubular necrosis while healing.
• In critically sick patients the degree as affected by some ATN tends toward recovery after some 2-3 months!
• Beyond the biopsy is best for kidney transplants so get NTA vs drug and rejection sorted!

4.7. Nuevos Marcadores de Daño Renal

• Recently advances have emerged toward finding tests done early to make an easy diagnostic approach to make a stratified prognostic factor.
• Usually tests test ones like cystatin C that get freely filtered alongside Beta-2-microglobulin but tests like Kidney injury molecule-1 & IL-18 and Netrin can also prove helpful!
• ADQI guidelines have been released pertaining to AKI pertaining in reference specifically to use across specific bio-markers.
• Tests such for protein markers, like tissue inhibitor of metalloproteinases prove strong!
• Markers like NGAL-Cystatin C -L-FABP as measured by TIMP or GFBP7 will get commercialized in short order as well.

5. TRATAMIENTO DE LA IRA

5.1. Tratamiento Médico

• The number one intervention should always include something aimed primarily against fixing this etiology toward something caused specifically through dehydration, so crystalloid treatment will come into consideration. (refer specifically towards the content as laid entirely across Table 6)
• Frequently a test with blood and electrolyte balance with a focus with something focused specifically upon potassium gets utilized. In situations of high volumes of hydrate, it proves highly advised that a central venous sample is taken-and that this can be kept at 8mmHg (10 cm H20).
• The main goal to manage sepsis in ER or hospitalized patients, they should act rapidly and diligently to provide empiric Abx and resuscitate the patient to a BP reading somewhere in excess, somewhere over 70 if not 80 mmHg to prevent it all from getting complicated!
• Bear in mind at times renal replacement and even worse some 50% tends to be the rough stats with regards patient mortality in most severe scenarios.
• In HRS paracentesis with albumin and Terlipressin use proves to benefit, but in those completely hardwired for said TIPSS use might also prove to get utilized!
• As a reminder as one enters on a state-of-art Parenchymal IRA with NTA- animal/human studies have unfortunately failed against benefits through endothelia-NO- or diuretic use as well.
• In autoimmune circumstances like pauci-immune circumstances, one might consider getting steroids/cyclosporine started and or with drug-induced cases where stopping the drug can prove advantageous. For obstructive reasons consult Urology!

5.2.Tratamiento Renal Sustitutivo

5.2.1.Indicaciones para el inicio de la terapia de sustitución

• The number one item includes what comes entirely under managing fluids for oliguria/anuria by means of some nutritional route/or just simply in all those scenarios when fluids/lungs start getting affected, or if some serious levels with potassium or just generally too skewed a profile begins and a need for something to maintain the maintenance, so dialysis has to get started!
• At times as some literature has showed that preemptive scenarios work best and help ease severity or prevent even worse down the road!

5.2.2. Variantes Técnicas de Tratamientos Renal Sustitutivo

5.2.2.1. Diálisis Peritoneal (DP)

• Despite coming across with great simplicity the downfall stems entirely through greater intraabdominal pressures resulting generally over impacted respiration.
• This route has a big NO with previous surgery and is only indicated in scenarios where funds or time do not prove enough to provide better.

5.2.2.2. Hemodiálisis Intermitente (HDI)

• A dialysis fluid prepped usually with acetate use has long since went out-and instead, bicarb is best.
• In our current scenario, its been shown that setting conditions somewhere near 14-15 may prove as best option to help ease tolerance during something like dialysis. Lowering somewhat around the 35C mark also helps the same objective!
• Devices designed now allow not to require anything extra (internal product) to make that work (inline dialysate!). An advantage of this devices allows measuring everything in device plus has volume variations to help ease conditions during this process. Furthermore water lines come portable to everywhere it will prove necessary!

5.2.2.3. Técnicas de Depuración Continuas (TDC)

• The first option emerging back around that time had nothing more than the arteriovenous mode, never mind the fancy ones. As an effect fluid got removed almost identical to glomeruli!
• Unfortunately, volume control was based solely through arterial supply (patient with pressure was one key). The next element centered at a